USD 11.27
(2.69%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 53.29 Million USD | -10.36% |
2022 | 59.44 Million USD | -3.08% |
2021 | 61.33 Million USD | -3.7% |
2020 | 63.68 Million USD | 54.09% |
2019 | 41.33 Million USD | 117.29% |
2018 | 19.02 Million USD | 5996.79% |
2017 | 312 Thousand USD | 103.81% |
2016 | -8.18 Million USD | -114.18% |
2015 | -3.82 Million USD | 20.15% |
2014 | -4.78 Million USD | 0.0% |
2013 | - USD | 100.0% |
2012 | -3.05 Million USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | -100.0% |
2007 | 6.45 Million USD | 2412.45% |
2006 | 257 Thousand USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 61.8 Million USD | 15.98% |
2024 Q2 | 62.46 Million USD | 1.06% |
2023 Q3 | 49.41 Million USD | -6.92% |
2023 Q4 | 53.29 Million USD | 7.85% |
2023 Q2 | 53.08 Million USD | -7.98% |
2023 FY | 53.29 Million USD | -10.36% |
2023 Q1 | 57.69 Million USD | -2.95% |
2022 Q1 | 79.03 Million USD | 28.86% |
2022 Q3 | 102.6 Million USD | 38.7% |
2022 Q4 | 59.44 Million USD | -42.07% |
2022 Q2 | 73.97 Million USD | -6.4% |
2022 FY | 59.44 Million USD | -3.08% |
2021 Q2 | 86.45 Million USD | 25.57% |
2021 FY | 61.33 Million USD | -3.7% |
2021 Q1 | 68.84 Million USD | 8.1% |
2021 Q4 | 61.33 Million USD | -8.86% |
2021 Q3 | 67.29 Million USD | -22.16% |
2020 Q1 | 48.09 Million USD | 16.37% |
2020 Q4 | 63.68 Million USD | 7.89% |
2020 Q2 | 54.39 Million USD | 13.08% |
2020 Q3 | 59.03 Million USD | 8.53% |
2020 FY | 63.68 Million USD | 54.09% |
2019 Q3 | 39.35 Million USD | 7.44% |
2019 FY | 41.33 Million USD | 117.29% |
2019 Q1 | 27.56 Million USD | 44.93% |
2019 Q2 | 36.62 Million USD | 32.86% |
2019 Q4 | 41.33 Million USD | 5.02% |
2018 Q4 | 19.02 Million USD | 52.76% |
2018 Q2 | 5.11 Million USD | 829.45% |
2018 Q1 | 550 Thousand USD | 76.28% |
2018 FY | 19.02 Million USD | 5996.79% |
2018 Q3 | 12.45 Million USD | 143.58% |
2017 Q4 | 312 Thousand USD | 0.0% |
2017 Q3 | - USD | 100.0% |
2017 Q2 | -5.24 Million USD | 0.0% |
2017 Q1 | - USD | 100.0% |
2017 FY | 312 Thousand USD | 103.81% |
2016 Q1 | - USD | 100.0% |
2016 FY | -8.18 Million USD | -114.18% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | -8.18 Million USD | 0.0% |
2015 Q1 | - USD | 100.0% |
2015 Q4 | -3.82 Million USD | 0.0% |
2015 FY | -3.82 Million USD | 20.15% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | -4.78 Million USD | 0.0% |
2014 FY | -4.78 Million USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | -2.76 Million USD | 9.58% |
2013 Q3 | -3.27 Million USD | -0.4% |
2013 Q4 | - USD | 100.0% |
2013 FY | - USD | 100.0% |
2013 Q2 | -3.26 Million USD | -18.16% |
2012 Q2 | -5.42 Million USD | 0.0% |
2012 Q3 | - USD | 100.0% |
2012 Q4 | -3.05 Million USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | -3.05 Million USD | 0.0% |
2011 Q3 | - USD | 100.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | -2.92 Million USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | - USD | 100.0% |
2010 Q1 | -2.61 Million USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 FY | - USD | -100.0% |
2008 Q3 | - USD | -100.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | 5.83 Million USD | 0.0% |
2008 Q1 | - USD | -100.0% |
2007 Q4 | 6.45 Million USD | 2355.13% |
2007 FY | 6.45 Million USD | 2412.45% |
2007 Q2 | 248 Thousand USD | 0.81% |
2007 Q1 | 246 Thousand USD | -4.28% |
2007 Q3 | 263 Thousand USD | 6.05% |
2006 Q1 | - USD | 0.0% |
2006 Q4 | 257 Thousand USD | -83.15% |
2006 FY | 257 Thousand USD | 0.0% |
2006 Q3 | 1.52 Million USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bright Green Corporation | - USD | -Infinity% |
Alpha Teknova, Inc. | 11.59 Million USD | -359.634% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 52.076% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -687.265% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -64.821% |
Cosmos Health Inc. | 4.78 Million USD | -1012.746% |
Journey Medical Corporation | 10.2 Million USD | -422.144% |
Embecta Corp. | 152.1 Million USD | 64.964% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 18.794% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -357.543% |
Pacira BioSciences, Inc. | 104.35 Million USD | 48.933% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -829.246% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -829.246% |
SCYNEXIS, Inc. | - USD | -Infinity% |
Safety Shot Inc | 1.86 Million USD | -2750.271% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -6480.987% |
Procaps Group, S.A. | 96.83 Million USD | 44.967% |
Theratechnologies Inc. | 6.06 Million USD | -778.503% |
Harrow Health, Inc. | 10.86 Million USD | -390.384% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1859.912% |
Biofrontera Inc. | 10.9 Million USD | -388.541% |
DURECT Corporation | 2.21 Million USD | -2301.532% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 31.157% |
Cronos Group Inc. | 30.33 Million USD | -75.649% |
OptiNose, Inc. | 8.05 Million USD | -561.823% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -5328999900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -835.071% |
Organogenesis Holdings Inc. | 28.25 Million USD | -88.617% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -1890.578% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1056.125% |
Radius Health, Inc. | 278.64 Million USD | 80.875% |
Universe Pharmaceuticals INC | 3.34 Million USD | -1493.95% |
ProPhase Labs, Inc. | 3.84 Million USD | -1287.399% |
Phibro Animal Health Corporation | 265.91 Million USD | 79.959% |
Procaps Group S.A. | 96.83 Million USD | 44.967% |
Alvotech | 74.43 Million USD | 28.405% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 98.464% |
Rockwell Medical, Inc. | 5.87 Million USD | -807.682% |
Aytu BioPharma, Inc. | 12.63 Million USD | -321.832% |
SIGA Technologies, Inc. | 64.21 Million USD | 17.017% |
Tilray Brands, Inc. | 252.08 Million USD | 78.86% |
Lifecore Biomedical, Inc. | 39.97 Million USD | -33.295% |
Shineco, Inc. | 1.58 Million USD | -3254.684% |
PetIQ, Inc. | 159.3 Million USD | 66.549% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 34980.677% |
Incannex Healthcare Limited | -10.01 Million USD | 632.102% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | -39.138% |
Alimera Sciences, Inc. | 1.87 Million USD | -2736.083% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | -41.405% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -3209.134% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -1088.713% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -20851.28% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -413.391% |
Hempacco Co., Inc. | 2.54 Million USD | -1995.863% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 28.405% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -11.499% |
Lantheus Holdings, Inc. | 64.02 Million USD | 16.772% |
Currenc Group, Inc. | 732.91 Thousand USD | -7171.006% |
Kamada Ltd. | 87.74 Million USD | 39.268% |
Indivior PLC | 141.79 Million USD | 62.419% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -10959.688% |
Flora Growth Corp. | 8.5 Million USD | -526.352% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -20851.28% |
Evolus, Inc. | 10.99 Million USD | -384.543% |
HUTCHMED (China) Limited | 50.25 Million USD | -6.033% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 49.647% |
Akanda Corp. | 1.28 Million USD | -4040.978% |